Virtu Financial LLC Kintara Therapeutics, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.14 - $6.8 $23,006 - $1.12 Million	164,330 New	164,330 $18,000
Q2 2022 Aug 09, 2022	SELL	$0.14 - $0.5 $5,780 - $20,646	-41,292 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.31 - $0.55 $7,322 - $12,991	-23,621 Reduced 36.39%	41,292 $16,000
Q4 2021 Feb 17, 2022	BUY	$0.51 - $1.04 $26,083 - $53,189	51,144 Added 371.44%	64,913 $33,000
Q3 2021 Nov 12, 2021	SELL	$0.82 - $2.3 $33,586 - $94,205	-40,959 Reduced 74.84%	13,769 $12,000
Q2 2021 Sep 17, 2021	BUY	$1.26 - $2.4 $16,274 - $30,998	12,916 Added 30.89%	54,728 $124,000
Q1 2021 May 19, 2021	BUY	$1.32 - $2.74 $32,629 - $67,730	24,719 Added 144.61%	41,812 $73,000
Q4 2020 Feb 24, 2021	BUY	$1.26 - $1.72 $21,537 - $29,399	17,093 New	17,093 $22,000

Ticker KTRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,807,296
Market Cap $17.8M
Description
Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme,...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.